Not everyone with NAFLD will experience the same liver benefit, so physicians must monitor individual outcomes and modify strategies accordingly
JAMA Intern Med 184(9):10561064 Zhang M, Lin C, Cai X, Jiao R, Bai S, Li Z et al (2025) One or two
The study draws on data on nearly 10,000 Colorado prescriptions of glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs over a 4-year period
While both peptides have a chemical structure that closely resembles -MSH, they differ in several important ways
One of the rare but serious risks is pancreatitis (inflammation of the pancreas), which may lead to severe stomach pain, fever, or vomiting that does not go away
GiustariniDTsikasDColomboGMilzaniADalle-DonneIFantiPet alPitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG) in biological samples: an elephant in the room